Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition (Q73686588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

E Hernández

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T Toledo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Alamo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Mon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J L Rodicio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Praga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

397-403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Idiopathic IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

A retrospective analysis of the natural history of primary IgA nephropathy worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Prognostic pathologic markers in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Microvascular disease and the progression of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Letter: Factor-VIII complex and endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Features of endothelial dysfunction in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Microalbuminuria and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

von Willebrand factor: clinical features of inherited and acquired disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

von Willebrand factor and development of diabetic nephropathy in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: frequency and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Long-term effects of calcium antagonists and angiotensin-converting enzyme inhibitors in patients with chronic renal failure of IgA nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Endothelium-dependent effects of converting-enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990285-7

7 January 2021

10.1016/S0272-6386(97)90285-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292569%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference